Formulation Of Bilayered Floating Tablets Of Atorvastatin And Niacin: Formulation And Evaluation Of Bilayered Floating Tablets Of Atorvastatin Calcium And Niacin. Cet article n’est pas disponible.
Langue : anglais
Edité par Lap Lambert Academic Publishing, 2012
- Livre broché
- Neuf

Vendeur : Revaluation Books, Exeter, Royaume-UniRevaluation Books
Vendeur avec une évaluation de 5 étoiles
Vendeur AbeBooks depuis 6 janvier 2003
Indisponible
Livre broché
Etat: Neuf
EUR 123,83
A propos de cet article
148 pages. 8.66x5.91x0.34 inches. In Stock.
N° de réf. du vendeur __3659268593
- Titre
- Formulation Of Bilayered Floating Tablets Of Atorvastatin And Niacin: Formulation And Evaluation Of Bilayered Floating Tablets Of Atorvastatin Calcium And Niacin
- Auteur
- Haripriya, Puthoori; Murthy, T.E.G.K.; Kaushik, Atul; Haripriya, Puthoori; Murthy, T.E.G.K.; Kaushik, Atul
- Éditeur
- Lap Lambert Academic Publishing
- Année de publication
- 2012
- État de l'article
- Brand New
- Reliure
- Paperback
- Langue
- anglais
- ISBN à 10 chiffres
- 3659268593
- ISBN à 13 chiffres
- 9783659268595
- Poids de l'article
- 0,27 kilogramme
In general, Cardiovascular Disease (CVD) is mainly associated with abnormal cholesterol levels (Hypercholesterolemia) in which there are increased levels of LDL and decreased levels of HDL in blood. This leads to atherosclerosis that later leads to myocardial infarction, stroke, and peripheral disease. Hence control of blood cholesterol levels is very much important to reduce the risk of CVD. In the present investigation, Atorvastatin Calcium (AT)(BCS Class II drug) an anti-hyperlipidemic agent belongs to the class Statins was formulated as an immediate release layer by using different excipients to improve the rate of dissolution. This reduces the levels of LDL and triglycerides in the blood to a major extent. On the other hand, Niacin (NA), a vitamin B3 was formulated as floating sustained release layer by using different combination of polymers to get desired drug release. Niacin in higher concentrations is used to treat hypercholesterolemia by reducing the levels of LDL, triglycerides to some extent and increases the levels of HDL to a major extent. Hence,the combination of AT and NA was found to be more beneficial than individual drugs in the treatment of hypercholesterolemia.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.
Présentation de l'éditeur
In general, Cardiovascular Disease (CVD) is mainly associated with abnormal cholesterol levels (Hypercholesterolemia) in which there are increased levels of LDL and decreased levels of HDL in blood. This leads to atherosclerosis that later leads to myocardial infarction, stroke, and peripheral disease. Hence control of blood cholesterol levels is very much important to reduce the risk of CVD. In the present investigation, Atorvastatin Calcium (AT)(BCS Class II drug) an anti-hyperlipidemic agent belongs to the class Statins was formulated as an immediate release layer by using different excipients to improve the rate of dissolution. This reduces the levels of LDL and triglycerides in the blood to a major extent. On the other hand, Niacin (NA), a vitamin B3 was formulated as floating sustained release layer by using different combination of polymers to get desired drug release. Niacin in higher concentrations is used to treat hypercholesterolemia by reducing the levels of LDL, triglycerides to some extent and increases the levels of HDL to a major extent. Hence,the combination of AT and NA was found to be more beneficial than individual drugs in the treatment of hypercholesterolemia.
« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.